Navigation Links
www.Joyn7030.com, A New Web Site Dedicated to Helping Women Fight Joint Pain, Launches
Date:10/17/2008

Site Offers Advice for Joint-Pain Sufferers Who are Confused and Concerned About Their Options for Fighting Joint Pain; Examines New Research That

Reveals Truth About Makeup of Joint Cartilage and Offers Hope

EGG HARBOR TOWNSHIP, N.J., Oct. 17 /PRNewswire/ -- A new Web site dedicated to helping women fight joint pain, http://www.Joyn7030.com, launched today. The site is designed to help joint-pain sufferers take control of their lives with a unique 70/30 joint-health plan. The site also examines new research that reveals the truth about the makeup of joint cartilage, provides expert opinions on why glucosamine has not met expectations in supporting joint health, and offers a place for women to connect and share ideas on living pain-free.

"Our goal is to help the many people suffering from joint pain live active, healthy, pain-free lives," said Leonard P. Smith, CEO, BSP Pharma, creator of the site. "Following the recent announcement from the National Center for Complementary and Alternative Medicine at the National Institutes of Health regarding the ineffectiveness of glucosamine and chondroitin in treating chronic joint conditions, many joint-pain sufferers are confused and concerned about their options. This site can help clear the confusion."

Because women have less joint cartilage than men, when it breaks down, it affects them in more places with more intensity. In fact, after menopause women experience a significant decline in joint collagen, which makes up 70 percent of cartilage and provides structure, strength and smoothness to the joint.

http://www.Joyn7030.com examines exciting new research that actually explains why glucosamine and chondroitin could not meet expectations as a comprehensive joint treatment because they are only 30 percent of the solution, and don't address the deterioration of Type II collagen,
'/>"/>

SOURCE http://www.Joyn7030.com
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Scripps Research Institute and IAVI launch worlds first dedicated HIV neutralizing antibody center
2. First Dedicated Cancer Hospital Coming to North Texas
3. Cleveland Clinic Launches Fully Dedicated International Comprehensive Critical Care Program
4. Medicexchange.com Launches a New Dedicated Nuclear Medicine and Molecular Imaging Community for Medical Imaging Professionals
5. Nonprofit Organization Dedicated to Helping Young Adult Cancer Survivors Raises $4500 for Leanna Elizalde
6. SCAN Health Plan Announces Creation of $205 Million Foundation Dedicated to the Needs of Seniors
7. Thomson Scientific To Honor Australias Top Researchers With Dedicated Australian Research Day
8. American Heart Association Themed Issue Journal Report: Journal Edition Dedicated to Womens Unique Hypertension Issues
9. StopMusclePain.com Launched as Only Website Dedicated to Reversing Back Pain
10. Video Feed: Jenny McCarthy Honored at LEGOLAND(R) Californias Tree Lighting Ceremony Dedicated to Autism Awareness
11. Special Olympics Special Spirit in China Award Of Excellence Presented to Dedicated Friends of Special Olympics and City of Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18News brief 3A Estrogen receptor alpha breast cancer patients and tamoxifen response 62159 1New stress related gene modulates high blood pressure in mice and men 62157 1New stress related gene modulates high blood pressure in mice and men 62157 2Type 1 Diabetes May Have a New Foe 62155 1Type 1 Diabetes May Have a New Foe 62155 2Type 1 Diabetes May Have a New Foe 62155 3